(Reuters) - Similac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly ...
As a former trial attorney with more than a decade of litigation experience, Jamie L. Pfeiffer writes trustworthy, engaging and informative content for law firm websites, legal publications and online ...
The CEO of Abbott Laboratories defended the company’s infant formula products Thursday, remarks that came as a trial continues this week in Missouri over allegations that Abbott’s formula led a ...
Similac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly bowel disease ...
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their premature-infant formulas can cause a bowel disease that severely sickened a baby ...
(Reuters) -A jury on Friday found that Abbott Laboratories' specialized formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to ...
As a former trial attorney with more than a decade of litigation experience, Jamie L. Pfeiffer writes trustworthy, engaging and informative content for law firm websites, legal publications and online ...
These NEC lawsuits are separate from ongoing litigation against Abbott over the shutdown of its Sturgis plant. The market’s back, and these 3 income stocks are thriving. See them here→ Abbott ...
Jurors in St. Clair County found that Mead Johnson was negligent and failed to warn about the risks that its preterm infant formula—which plaintiff Jasmine Watson’s baby, Chance Dean, was taking ...
Jurors in St. Clair County found that Mead Johnson was negligent and failed to warn about the risks of its preterm infant formula, which plaintiff Jasmine Watson's baby, Chance Dean, was taking before ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results